----
Current ValuationThe current P/E ratio is -7.13, above the reasonable range, cheaper than 1.05% of the time in the past 5 years, and the industry ranks 75/95, the industry Median -0.38.
-7.13xP/E
$2.60Stock price
$-0.36Earnings per share
-7.13xP/E
Stock price$2.60Earnings per share$-0.36
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -26.24x
- Typical range
- -38.89x–-15.95x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
014284256
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
NJDCYUSNidec | -4.04x | -- | $15.04B |
ATKRUSAtkore | -19.70x | 275.56% | $3.20B |
PLUGUSPlug Power | -1.47x | 72.21% | $2.42B |
FCELUSFuelCell Energy | -7.73x | 61.54% | $1.38B |
FLNCUSFluence Energy | -17.01x | 198.41% | $1.38B |
AMPXUSAmprius Tech | -35.72x | 79.05% | $1.37B |
EOSEUSEOS Energy Enterprises | -0.98x | 127.79% | $1.01B |
ADSEUSAds-Tec Energy | -7.41x | -- | $709.00M |
HYLNUSHyliion | -12.90x | 7.58% | $673.31M |
BLDPUSBallard Power | -7.57x | 38.63% | $584.92M |
ARRYUSArray Tech | -3.90x | 135.65% | $577.53M |
ENVXUSEnovix | -3.23x | 7.13% | $548.62M |
FACUSFactorial Energy | -7.73x | 95.37% | $543.68M |
SESUSSES AI | -4.27x | 18.77% | $290.46M |
EAFUSGraftech | -1.30x | 31.91% | $230.92M |
CHPTUSChargePoint | -1.24x | 44.59% | $218.29M |
NEOVUSNeoVolta | -7.13x | 30.45% | $153.04M |
SKYXUSSKYX Platforms | -4.41x | 27.68% | $150.33M |
KULRUSKULR Tech | -1.11x | 8.97% | $113.75M |
ULBIUSUltralife | -15.80x | -- | $103.48M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
